Abstract
In the US, the current standard for the treatment of acute ischemic stroke (AIS) is the intravenous administration of recombinant tissue plasminogen activator (rtPA) if the patient presents within 4.5 hours of symptom onset. Citation: Yi Lu, David L. McDonagh, Lingzhong Meng. Anesthetic care for acute ischemic stroke: facts and aspirations. J Anesth Perioper Med 2015; 2: 283-6. doi: 10.24015/JAPM.2015.0038This is an open-access article, published by Evidence Based Communications (EBC). This work is licensed under the Creative Commons Attribution 4.0 International License, which permits unrestricted use, distribution, and reproduction in any medium or format for any lawful purpose. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
